and recommendation

StemCells, Inc. (STEM)
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimers disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
- October 1, 2014 - 9:34am | Regulatory
- September 29, 2014 - 10:34am | Earnings
- September 29, 2014 - 9:03am | Financings
- September 24, 2014 - 11:03am | Research Notes
- September 24, 2014 - 9:15am | IP & Patents
- September 22, 2014 - 10:53am | Research Notes
- September 18, 2014 - 9:34am | Regulatory
- September 17, 2014 - 9:04am | Financings
- September 15, 2014 - 7:26pm | Spotlight
- September 12, 2014 - 9:16am | Out and About
- September 11, 2014 - 10:20am | Research Notes
- September 11, 2014 - 7:51am | IP & Patents
- September 8, 2014 - 3:18pm | Model Portfolio
- September 5, 2014 - 9:54am | IP & Patents
- September 4, 2014 - 9:26am | BOD & C-Suite Updates
- September 3, 2014 - 10:20am | IP & Patents
- September 2, 2014 - 9:34am | BOD & C-Suite Updates
- August 29, 2014 - 9:56am | IP & Patents
- August 19, 2014 - 12:08am | Earnings
- August 18, 2014 - 11:27pm | Earnings